| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 10987311 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 368 journal articles in the PubMed database | Email to a friend | | |
| Zarour HM, Storkus WJ, Brusic V, et al.
NY-ESO-1 encodes DRB1*0401-restricted epitopes recognized by melanoma-reactive CD4+ T cells. [Journal Article]
Cancer Res 2000 Sep 1; 60(17):4946-52.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Mandic M, Castelli F, Janjic B, et al.
One NY-ESO-1-derived epitope that promiscuously binds to multiple HLA-DR and HLA-DP4 molecules and stimulates autologous CD4+ T cells from patients with NY-ESO-1-expressing melanoma. [Journal Article]
J Immunol 2005 Feb 1; 174(3):1751-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Zarour HM, Maillere B, Brusic V, et al.
NY-ESO-1 119-143 is a promiscuous major histocompatibility complex class II T-helper epitope recognized by Th1- and Th2-type tumor-reactive CD4+ T cells. [Journal Article]
Cancer Res 2002 Jan 1; 62(1):213-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Zeng G, Touloukian CE, Wang X, et al.
Identification of CD4+ T cell epitopes from NY-ESO-1 presented by HLA-DR molecules. [Journal Article]
J Immunol 2000 Jul 15; 165(2):1153-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Mandic M, Almunia C, Vicel S, et al.
The alternative open reading frame of LAGE-1 gives rise to multiple promiscuous HLA-DR-restricted epitopes recognized by T-helper 1-type tumor-reactive CD4+ T cells. [Journal Article]
Cancer Res 2003 Oct 1; 63(19):6506-15.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Slager EH, Borghi M, van der Minne CE, et al.
CD4+ Th2 cell recognition of HLA-DR-restricted epitopes derived from CAMEL: a tumor antigen translated in an alternative open reading frame. [Journal Article]
J Immunol 2003 Feb 1; 170(3):1490-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Jäger E, Jäger D, Karbach J, et al.
Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma. [Journal Article]
J Exp Med 2000 Feb 21; 191(4):625-30.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Slager EH, van der Minne CE, Krüse M, et al.
Identification of multiple HLA-DR-restricted epitopes of the tumor-associated antigen CAMEL by CD4+ Th1/Th2 lymphocytes. [Journal Article]
J Immunol 2004 Apr 15; 172(8):5095-102.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Zarour HM, Kirkwood JM, Kierstead LS, et al.
Melan-A/MART-1(51-73) represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4(+) T cells. [Journal Article]
Proc Natl Acad Sci U S A 2000 Jan 4; 97(1):400-5.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
